URESE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Urese, and what generic alternatives are available?
Urese is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in URESE is benzthiazide. There is one drug master file entry for this compound. Additional details are available on the benzthiazide profile page.
Summary for URESE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 63 |
Patent Applications: | 3,668 |
Formulation / Manufacturing: | see details |
DailyMed Link: | URESE at DailyMed |
US Patents and Regulatory Information for URESE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | URESE | benzthiazide | TABLET;ORAL | 012128-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |